Format

Send to

Choose Destination
Asian J Androl. 2018 Sep 7. doi: 10.4103/aja.aja_70_18. [Epub ahead of print]

Lycopene exerts anti-inflammatory effect to inhibit prostate cancer progression.

Author information

1
Department of Surgery II, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
2
Department of Urology Surgery I, Cangzhou Central Hospital, Cangzhou 061000, China.

Abstract

Lycopene is a natural compound that alleviates oxidative stress and inflammation, exerting therapeutic effects in a number of cancers. The aim of this study is to investigate the efficacy of lycopene in inhibiting prostate cancer. Cell viability assays indicated the dose- and time-dependent toxicity of lycopene in prostate cancer cells. Annexin V/propidium iodide double-staining assays revealed the strong apoptotic effects of lycopene. The levels of inflammatory factors, including interleukin-1 (IL1), IL6, IL8, and tumor necrosis factor-α (TNF-α), in lycopene-treated cells were also reduced by lycopene treatment. With the increasing dose of lycopene, the survival of mice bearing prostate cancer xenografts was significantly improved (P < 0.01), and the tumor burden was significantly reduced (P < 0.01). Our results indicate that lycopene is a promising chemotherapy drug, which inhibits prostate cancer progression by suppressing the inflammatory response.

KEYWORDS:

dietary supplement; inflammation; lycopene; prostate cancer

PMID:
30198495
DOI:
10.4103/aja.aja_70_18
Free full text

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd
Loading ...
Support Center